Archive for the 'Asbestos & Mesothelioma Studies' Category

Asbestos & Mesothelioma Studies news feed.

First FDA Approved Mesothelioma Treatment in 15 Years to be Used Soon

A new cancer treatment using electricity has been approved for use in mesothelioma patients. The NovoTTF-100L uses Tumor Treating Fields, which are electric signals tuned to a specific frequency, to disrupt cancerous cell division. The fields are applied to the patient with adhesive bandages and are used for at least 18 hours a day. This

more

CAR T-Cell Therapy Could Soon be used on Mesothelioma Patients

An immunotherapy treatment that utilizes T cells to fight cancer may soon be covered by Medicare for mesothelioma patients. Immunotherapy is still an emerging set of cancer treatments that utilizes the patient’s own immune system to fight and kill cancer cells. The specific treatment that uses T cells is called chimeric antigen receptor (CAR) T-cell

more

MicroRNA Could be used to Quickly Diagnose Mesothelioma

Biomarkers are measureable substances that indicate if someone has a disease. Doctors and researchers are able to find different substances within a person’s body and deduce that the person has a specific type of cancer. Researchers have found a relatively new biomarker called microRNA, which could possibly be used to diagnose mesothelioma. MicroRNAs control gene

more

Mesothelioma Diagnosis Rates Have Remained Stable even though Mesothelioma Survival has Improved

It was found that the number of pleural mesothelioma diagnoses has stayed the same, while the survival rate for people with the disease has slightly improved. Once asbestos was not used as much because of multiple regulations, the number of diagnoses of mesothelioma was predicted to go down. Instead, the number of diagnoses has remained

more

Dendritic Cell Therapy Could be used to Treat Mesothelioma

Immunotherapy is a blossoming field that is becoming more advanced. Instead of other treatments that kill healthy cells in addition to killing cancerous cells, immunotherapy uses the body’s immune system to fight cancer cells, leaving healthy non-cancerous cells intact. It is a better treatment because it is very effective, more efficient, and is easier on

more

Phase I Clinical Trial Yields Positive Results In Latest Immunotherapy Treatment

The immune system is the body’s first line of defense when fighting off any illness, attacking foreign organisms or other substances that may harm or threaten the over health of the body. When the immune system is compromised, the body is unable to fight infections and becomes weak as the illness takes over. For those

more

Peripheral Neuropathy Pain Reduced in Mesothelioma Patients

Avastin (bevacizumab) is a type of chemotherapy treatment that slows tumor growth by blocking the protein that is responsible for forming new blood vessels, which is what tumors need to thrive. By blocking these blood vessels, tumor growth is slowed. For those suffering from mesothelioma, hindering tumor growth can greatly improve the quality of life

more

Potential New Treatment Acts as a Sealant for Pleural Mesothelioma Tumors

Pleural mesothelioma, caused by exposure to asbestos is a rare cancer – only 3,000 cases are diagnosed in the U.S. each year – but it is highly aggressive. There is no cure for plural mesothelioma but findings published in the Journal of Thoracic and Cardiovascular Surgery reveal that a new type of combination treatment specifically

more

First FDA Approved Treatment for Mesothelioma in 15 Years

In the Fall of 2018 scientists and researchers from Novocure, an oncology company that specializes in treating solid tumors, were hopeful their latest success with Tumor Treating Fields therapy would lead to FDA approval and ultimately, more options for those suffering from mesothelioma. After a successful clinical trial, these hopes became a reality as the

more

Survival Factors for Mesothelioma Highlighted by University of Pittsburgh Medical Center

According to GLOBOCAN 2018 statistics, each year there are 30,443 mesothelioma cases worldwide, and of those 30,443, 25,576 pass away.  With close to 85 percent of those diagnosed succumbing to the disease, mesothelioma remains one of the most deadly cancers as there is no cure. However, surviving a mesothelioma diagnosis is not entirely impossible as

more

Less Invasive Surgery Produces Longer Median Survival in Mesothelioma Patients

Surgical techniques for those suffering from mesothelioma depend on how far the cancer has spread and if the patient is healthy enough to withstand such an invasive procedure. In many cases, the cancer has already spread too far and quickly, so surgery is not an option. For those able to treat their cancer with surgery,

more

Why Does Asbestos-Related Disease Continue to Rise?

In early 2017, the Centers for Disease Control and Prevention (CDC) reported that despite the decline of asbestos use once the product became regulated in the United States, mesothelioma rates continue to rise, with a total of 45,221 deaths in the United States alone from 1999 to 2015. Scientists and researchers struggle to pinpoint reasoning

more

Targeted Immunotherapy Warrants More Research for Those Suffering from Pleural Mesothelioma

Late last month, the Clinical Respiratory Journal released their findings on the efficacy of intrapleural immunotherapy, which is a highly targeted approach of receiving immunotherapy treatment for those suffering from mesothelioma. Mesothelioma is a cancer caused only by asbestos exposure. Since asbestos is the only known cause, mesothelioma is sometimes referred to as “asbestos cancer.”

more

Understanding the Signs and Symptoms of Asbestos Disease

Asbestos was once considered something of a wonder material for its durability and its resistance to heat and corrosion. There was a time when it could be found in textiles, drywall, clothing, gaskets, insulation, cement, pumps, brakes, machinery and other building materials. That changed years ago when it was discovered that asbestos exposure could be linked to

more

New Clinical Trial Underway for Immunotherapy Treatment; CA-170

A new immunotherapy treatment that has recently been administered to a patient suffering from mesothelioma has researchers and scientists optimistic that if results are positive, this treatment could be more effective than Keytruda, the immunotherapy treatment that has had major success in non-small cell lung cancer  The name of the treatment is CA-170, and while

more

Last update: April 01, 2019. 03:30:08 pm.